Emerging drugs for Hodgkin's lymphoma

Expert Opinion on Emerging Drugs
Boris BöllV Diehl

Abstract

Although to date most patients with Hodgkin's lymphoma (HL) can be cured, the current treatment is associated with acute and long-term complications such as infertility, cardiovascular damage and secondary malignancies. Moreover, novel effective therapies are urgently needed for elderly patients and for patients relapsing after high-dose chemotherapy. Currently emerging promising approaches include drugs targeting cell surface structures by mAbs and immunotoxins, as well as small molecules targeting intracellular proteins. This article includes clinical trials published within the past 3 decades and early results reported in international conferences. This article summarizes the biological basis and early clinical data on emerging drugs for HL. To date, several new drugs are being tested for HL that are expected to change the approach in both first-line and relapsed patients.

References

Jan 1, 1997·British Journal of Cancer·W C VooijsG C de Gast
Sep 5, 2002·The Journal of Pathology·Ipatia A Doussis-AnagnostopoulouKevin C Gatter
Oct 31, 2002·British Journal of Haematology·Gail L StarkUNKNOWN Northern Region Lymphoma Group
Feb 6, 2003·International Journal of Hematology·Ryouichi HorieToshiki Watanabe
Feb 15, 2003·Blood·Bradley C EkstrandSandra J Horning
Aug 12, 2003·Oncogene·Lawrence S Young, Paul G Murray
Jan 1, 2004·The Lancet Oncology·Roman K ThomasVolker Diehl
Mar 23, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hinrich P HansenAndreas Engert
Dec 22, 2004·The Journal of Experimental Medicine·Catherine M BollardHelen E Heslop
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Myron S CzuczmanBryan R Leigh
Jul 13, 2005·European Journal of Haematology. Supplementum·P BorchmannA Engert
Jul 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roland SchnellAndreas Engert
Aug 3, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J KreitmanIra Pastan
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel ReVolker Diehl
Sep 22, 2005·Nature Reviews. Cancer·Luke Whitesell, Susan L Lindquist
Nov 23, 2005·Oncology·Napoleone Ferrara
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ralf KüppersAndreas Josting
Jun 20, 2006·Current Opinion in Pharmacology·Nessa Carey, Nicholas B La Thangue
Aug 3, 2006·Nature Reviews. Drug Discovery·Sandrine FaivreEric Raymond
Nov 7, 2006·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Michael FuchsDaniel Re
Mar 29, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·René-Olivier CasasnovasUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte
May 23, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen M AnsellPeter Borchmann
Oct 3, 2007·Hematology/oncology Clinics of North America·Gunilla EnbladGunnar Nilsson
Oct 3, 2007·Hematology/oncology Clinics of North America·Berthe M P Aleman, Flora E van Leeuwen
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Asher A Chanan-Khan, Bruce D Cheson

❮ Previous
Next ❯

Citations

Jun 18, 2011·Current Opinion in Oncology·Magnus BjörkholmJan Sjöberg
Sep 29, 2011·International Journal of Cancer. Journal International Du Cancer·Marco GiaisiMin Li-Weber
Apr 5, 2013·International Journal of Cancer. Journal International Du Cancer·Antonino NatoliMin Li-Weber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.